메뉴 건너뛰기




Volumn 11, Issue 6, 2005, Pages 440-449

Potentially hazardous drug interactions with psychotropics

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPRAZOLAM; AMITRIPTYLINE; ANTACID AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CLOMIPRAMINE; CYTOCHROME P450; DIAZEPAM; GLUCURONOSYLTRANSFERASE; GLYCOPROTEIN P; LAMOTRIGINE; LEVODOPA; LITHIUM; MONOAMINE OXIDASE INHIBITOR; MORPHINE; NALOXONE; OPIATE; PHENOBARBITAL; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; PROTEINASE INHIBITOR; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID;

EID: 27844536375     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.11.6.440     Document Type: Article
Times cited : (39)

References (15)
  • 1
    • 0036885908 scopus 로고    scopus 로고
    • Emerging significance of P-glycoprotein in understanding drug disposition and drug interactions in psychopharmacology
    • Carson, S. W., Ousmanou, A. D. & Hoyler, S. L. (2002) Emerging significance of P-glycoprotein in understanding drug disposition and drug interactions in psychopharmacology. Psychopharmacology Bulletin, 36, 67-81
    • (2002) Psychopharmacology Bulletin , vol.36 , pp. 67-81
    • Carson, S.W.1    Ousmanou, A.D.2    Hoyler, S.L.3
  • 2
    • 0003109734 scopus 로고    scopus 로고
    • Role of the cytochrome p4503A subfamily in drug interactions
    • Jan
    • Cupp, M. J. & Tracy, T. S. (1997) Role of the cytochrome p4503A subfamily in drug interactions. US Pharmacist, Jan., HS9-21.
    • (1997) US Pharmacist
    • Cupp, M.J.1    Tracy, T.S.2
  • 3
    • 0037307139 scopus 로고    scopus 로고
    • Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interaction
    • Daniel, W. A. (2003) Mechanisms of cellular distribution of psychotropic drugs. Significance for drug action and interaction. Progress in Neuropsychopharmacology and Biological Psychiatry, 27, 65-73.
    • (2003) Progress in Neuropsychopharmacology and Biological Psychiatry , vol.27 , pp. 65-73
    • Daniel, W.A.1
  • 4
    • 18844430960 scopus 로고    scopus 로고
    • Unwanted effects of psychotropic drugs: 2. Drug interactions, effects during pregnancy and breast-feeding, pharmaco-vigilance and medico-legal considerations
    • (2nd edn) (ed. D. J. King), London: Gaskell
    • Edwards, J. G. (2004) Unwanted effects of psychotropic drugs: 2. Drug interactions, effects during pregnancy and breast-feeding, pharmaco-vigilance and medico-legal considerations. Seminars in Clinical Psychopharmacology (2nd edn) (ed. D. J. King), pp. 601-660. London: Gaskell.
    • (2004) Seminars in Clinical Psychopharmacology , pp. 601-660
    • Edwards, J.G.1
  • 7
    • 15244342411 scopus 로고    scopus 로고
    • UDP-glucuronosyltransferases and clinical drug-drug interactions
    • Kiang, T. K. L., Ensom, M. H. H. & Chang, T. K. H. (2005) UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacology and Therapeutics, 106, 97-132.
    • (2005) Pharmacology and Therapeutics , vol.106 , pp. 97-132
    • Kiang, T.K.L.1    Ensom, M.H.H.2    Chang, T.K.H.3
  • 8
    • 0036229852 scopus 로고    scopus 로고
    • Drugs as P-glycoprotein substrates, inhibitors and inducers
    • Kim, R. B. (2002) Drugs as P-glycoprotein substrates, inhibitors and inducers. Drug Metabolism Reviews, 34, 47-54.
    • (2002) Drug Metabolism Reviews , vol.34 , pp. 47-54
    • Kim, R.B.1
  • 9
    • 0037229942 scopus 로고    scopus 로고
    • Role of P-glycoprotein in pharmacokinetics
    • Lin, J. H. & Yamazaki, M. (2003) Role of P-glycoprotein in pharmacokinetics. Clinical Pharmacokinetics, 42, 59-98.
    • (2003) Clinical Pharmacokinetics , vol.42 , pp. 59-98
    • Lin, J.H.1    Yamazaki, M.2
  • 10
    • 0026254621 scopus 로고
    • Genotype or phenotype: The definition of a pharmacogenetic polymorphism
    • Meyer, U. A. (1991) Genotype or phenotype: the definition of a pharmacogenetic polymorphism. Pharmacogenetics, 1, 66-67.
    • (1991) Pharmacogenetics , vol.1 , pp. 66-67
    • Meyer, U.A.1
  • 11
    • 9044254525 scopus 로고    scopus 로고
    • P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
    • Nelson, D. R., Koymans, L., Kamataki, T., et al (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1-42.
    • (1996) Pharmacogenetics , vol.6 , pp. 1-42
    • Nelson, D.R.1    Koymans, L.2    Kamataki, T.3
  • 12
    • 0035254858 scopus 로고    scopus 로고
    • Clinical pharmacogenomics: Applications in pharmaceutical R&D
    • Norton, R. M. (2001) Clinical pharmacogenomics: applications in pharmaceutical R&D. Drug Discovery Today, 6, 180-185.
    • (2001) Drug Discovery Today , vol.6 , pp. 180-185
    • Norton, R.M.1
  • 14
    • 0037115525 scopus 로고    scopus 로고
    • Pharmacogenetics affects dosing, efficacy and toxicity of cytochrome p450 metabolized drugs
    • Rogers, J. F., Nafziger, A. N. & Bertino, J. S. (2002) Pharmacogenetics affects dosing, efficacy and toxicity of cytochrome p450 metabolized drugs. American Journal of Medicine, 113, 746-750.
    • (2002) American Journal of Medicine , vol.113 , pp. 746-750
    • Rogers, J.F.1    Nafziger, A.N.2    Bertino, J.S.3
  • 15
    • 0037309793 scopus 로고    scopus 로고
    • Antipsychotics and QT prolongation
    • Taylor, D. M. (2003) Antipsychotics and QT prolongation. Acta Psychiatrica Scandinavica, 109, 85-95.
    • (2003) Acta Psychiatrica Scandinavica , vol.109 , pp. 85-95
    • Taylor, D.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.